BUILDERS FIRSTSOURCE INC (BLDR) Stock Fundamental Analysis

NYSE:BLDR • US12008R1077

99.41 USD
-4.88 (-4.68%)
At close: Mar 2, 2026
99.6302 USD
+0.22 (+0.22%)
After Hours: 3/2/2026, 8:04:22 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Overall BLDR gets a fundamental rating of 4 out of 10. We evaluated BLDR against 42 industry peers in the Building Products industry. BLDR has an average financial health and profitability rating. BLDR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • BLDR had positive earnings in the past year.
  • BLDR had a positive operating cash flow in the past year.
  • BLDR had positive earnings in each of the past 5 years.
  • Each year in the past 5 years BLDR had a positive operating cash flow.
BLDR Yearly Net Income VS EBIT VS OCF VS FCFBLDR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • The Return On Assets of BLDR (3.87%) is comparable to the rest of the industry.
  • BLDR has a Return On Equity (10.00%) which is in line with its industry peers.
  • BLDR has a worse Return On Invested Capital (6.62%) than 61.90% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BLDR is above the industry average of 11.86%.
  • The 3 year average ROIC (13.95%) for BLDR is well above the current ROIC(6.62%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.87%
ROE 10%
ROIC 6.62%
ROA(3y)9.58%
ROA(5y)14.16%
ROE(3y)22.55%
ROE(5y)31.79%
ROIC(3y)13.95%
ROIC(5y)19.93%
BLDR Yearly ROA, ROE, ROICBLDR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • Looking at the Profit Margin, with a value of 2.86%, BLDR is in line with its industry, outperforming 40.48% of the companies in the same industry.
  • In the last couple of years the Profit Margin of BLDR has declined.
  • With a Operating Margin value of 5.18%, BLDR is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of BLDR has declined.
  • BLDR has a Gross Margin of 30.39%. This is comparable to the rest of the industry: BLDR outperforms 52.38% of its industry peers.
  • In the last couple of years the Gross Margin of BLDR has grown nicely.
Industry RankSector Rank
OM 5.18%
PM (TTM) 2.86%
GM 30.39%
OM growth 3Y-32.17%
OM growth 5Y-4.02%
PM growth 3Y-38.13%
PM growth 5Y-4.83%
GM growth 3Y-3.75%
GM growth 5Y3.19%
BLDR Yearly Profit, Operating, Gross MarginsBLDR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BLDR is still creating some value.
  • The number of shares outstanding for BLDR has been reduced compared to 1 year ago.
  • Compared to 5 years ago, BLDR has less shares outstanding
  • The debt/assets ratio for BLDR is higher compared to a year ago.
BLDR Yearly Shares OutstandingBLDR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BLDR Yearly Total Debt VS Total AssetsBLDR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 2.75 indicates that BLDR is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of BLDR (2.75) is comparable to the rest of the industry.
  • BLDR has a debt to FCF ratio of 5.21. This is a neutral value as BLDR would need 5.21 years to pay back of all of its debts.
  • BLDR has a Debt to FCF ratio (5.21) which is in line with its industry peers.
  • BLDR has a Debt/Equity ratio of 1.02. This is a high value indicating a heavy dependency on external financing.
  • BLDR's Debt to Equity ratio of 1.02 is on the low side compared to the rest of the industry. BLDR is outperformed by 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 5.21
Altman-Z 2.75
ROIC/WACC0.73
WACC9.04%
BLDR Yearly LT Debt VS Equity VS FCFBLDR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

  • BLDR has a Current Ratio of 1.86. This is a normal value and indicates that BLDR is financially healthy and should not expect problems in meeting its short term obligations.
  • BLDR has a Current ratio (1.86) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.16 indicates that BLDR should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.16, BLDR perfoms like the industry average, outperforming 54.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.16
BLDR Yearly Current Assets VS Current LiabilitesBLDR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • BLDR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.24%.
  • Measured over the past years, BLDR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.40% on average per year.
  • Looking at the last year, BLDR shows a decrease in Revenue. The Revenue has decreased by -7.38% in the last year.
  • BLDR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.16% yearly.
EPS 1Y (TTM)-40.24%
EPS 3Y-28.14%
EPS 5Y17.4%
EPS Q2Q%-51.52%
Revenue 1Y (TTM)-7.38%
Revenue growth 3Y-12.57%
Revenue growth 5Y12.16%
Sales Q2Q%2.37%

3.2 Future

  • Based on estimates for the next years, BLDR will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.16% on average per year.
  • The Revenue is expected to grow by 4.01% on average over the next years.
EPS Next Y-11.26%
EPS Next 2Y7.34%
EPS Next 3Y14.16%
EPS Next 5YN/A
Revenue Next Year-0.62%
Revenue Next 2Y2.63%
Revenue Next 3Y4.01%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLDR Yearly Revenue VS EstimatesBLDR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B
BLDR Yearly EPS VS EstimatesBLDR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 14.43 indicates a correct valuation of BLDR.
  • Based on the Price/Earnings ratio, BLDR is valued a bit cheaper than the industry average as 73.81% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of BLDR to the average of the S&P500 Index (27.13), we can say BLDR is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 16.26 indicates a correct valuation of BLDR.
  • 71.43% of the companies in the same industry are more expensive than BLDR, based on the Price/Forward Earnings ratio.
  • BLDR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.11.
Industry RankSector Rank
PE 14.43
Fwd PE 16.26
BLDR Price Earnings VS Forward Price EarningsBLDR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BLDR is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, BLDR is valued cheaply inside the industry as 80.95% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.88
EV/EBITDA 11.46
BLDR Per share dataBLDR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • BLDR's earnings are expected to grow with 14.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.83
EPS Next 2Y7.34%
EPS Next 3Y14.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • BLDR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BUILDERS FIRSTSOURCE INC

NYSE:BLDR (3/2/2026, 8:04:22 PM)

After market: 99.6302 +0.22 (+0.22%)

99.41

-4.88 (-4.68%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)02-17
Earnings (Next)04-29
Inst Owners104.69%
Inst Owner Change-5.29%
Ins Owners2.49%
Ins Owner Change0.08%
Market Cap10.99B
Revenue(TTM)15.19B
Net Income(TTM)435.20M
Analysts71.33
Price Target131.26 (32.04%)
Short Float %4.19%
Short Ratio2.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.45%
Min EPS beat(2)-11.6%
Max EPS beat(2)12.49%
EPS beat(4)3
Avg EPS beat(4)3.94%
Min EPS beat(4)-11.6%
Max EPS beat(4)12.49%
EPS beat(8)7
Avg EPS beat(8)6.47%
EPS beat(12)11
Avg EPS beat(12)20.34%
EPS beat(16)15
Avg EPS beat(16)32.8%
Revenue beat(2)1
Avg Revenue beat(2)-2.26%
Min Revenue beat(2)-4.82%
Max Revenue beat(2)0.31%
Revenue beat(4)1
Avg Revenue beat(4)-2.35%
Min Revenue beat(4)-4.82%
Max Revenue beat(4)0.31%
Revenue beat(8)1
Avg Revenue beat(8)-4.56%
Revenue beat(12)4
Avg Revenue beat(12)-2.6%
Revenue beat(16)8
Avg Revenue beat(16)1.22%
PT rev (1m)-2.06%
PT rev (3m)-4.93%
EPS NQ rev (1m)-50.46%
EPS NQ rev (3m)-54.66%
EPS NY rev (1m)-2.99%
EPS NY rev (3m)-7.88%
Revenue NQ rev (1m)-4.69%
Revenue NQ rev (3m)-6.02%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-1.05%
Valuation
Industry RankSector Rank
PE 14.43
Fwd PE 16.26
P/S 0.72
P/FCF 12.88
P/OCF 9.04
P/B 2.53
P/tB N/A
EV/EBITDA 11.46
EPS(TTM)6.89
EY6.93%
EPS(NY)6.11
Fwd EY6.15%
FCF(TTM)7.72
FCFY7.76%
OCF(TTM)11
OCFY11.06%
SpS137.37
BVpS39.36
TBVpS-8.76
PEG (NY)N/A
PEG (5Y)0.83
Graham Number78.11
Profitability
Industry RankSector Rank
ROA 3.87%
ROE 10%
ROCE 8.14%
ROIC 6.62%
ROICexc 6.75%
ROICexgc 15.37%
OM 5.18%
PM (TTM) 2.86%
GM 30.39%
FCFM 5.62%
ROA(3y)9.58%
ROA(5y)14.16%
ROE(3y)22.55%
ROE(5y)31.79%
ROIC(3y)13.95%
ROIC(5y)19.93%
ROICexc(3y)14.13%
ROICexc(5y)20.13%
ROICexgc(3y)32.17%
ROICexgc(5y)46.7%
ROCE(3y)17.15%
ROCE(5y)24.51%
ROICexgc growth 3Y-43.15%
ROICexgc growth 5Y-9.26%
ROICexc growth 3Y-42.43%
ROICexc growth 5Y-16.42%
OM growth 3Y-32.17%
OM growth 5Y-4.02%
PM growth 3Y-38.13%
PM growth 5Y-4.83%
GM growth 3Y-3.75%
GM growth 5Y3.19%
F-Score5
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 5.21
Debt/EBITDA 3.21
Cap/Depr 61.31%
Cap/Sales 2.39%
Interest Coverage 3.02
Cash Conversion 88.24%
Profit Quality 196.07%
Current Ratio 1.86
Quick Ratio 1.16
Altman-Z 2.75
F-Score5
WACC9.04%
ROIC/WACC0.73
Cap/Depr(3y)71.45%
Cap/Depr(5y)64.89%
Cap/Sales(3y)2.5%
Cap/Sales(5y)2.03%
Profit Quality(3y)151.11%
Profit Quality(5y)131.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-40.24%
EPS 3Y-28.14%
EPS 5Y17.4%
EPS Q2Q%-51.52%
EPS Next Y-11.26%
EPS Next 2Y7.34%
EPS Next 3Y14.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.38%
Revenue growth 3Y-12.57%
Revenue growth 5Y12.16%
Sales Q2Q%2.37%
Revenue Next Year-0.62%
Revenue Next 2Y2.63%
Revenue Next 3Y4.01%
Revenue Next 5YN/A
EBIT growth 1Y-50.7%
EBIT growth 3Y-40.7%
EBIT growth 5Y7.65%
EBIT Next Year35.74%
EBIT Next 3Y19.17%
EBIT Next 5YN/A
FCF growth 1Y-42.81%
FCF growth 3Y-36.03%
FCF growth 5Y41.96%
OCF growth 1Y-35.07%
OCF growth 3Y-30.35%
OCF growth 5Y36.13%

BUILDERS FIRSTSOURCE INC / BLDR FAQ

Can you provide the ChartMill fundamental rating for BUILDERS FIRSTSOURCE INC?

ChartMill assigns a fundamental rating of 4 / 10 to BLDR.


What is the valuation status of BUILDERS FIRSTSOURCE INC (BLDR) stock?

ChartMill assigns a valuation rating of 5 / 10 to BUILDERS FIRSTSOURCE INC (BLDR). This can be considered as Fairly Valued.


Can you provide the profitability details for BUILDERS FIRSTSOURCE INC?

BUILDERS FIRSTSOURCE INC (BLDR) has a profitability rating of 5 / 10.


Can you provide the financial health for BLDR stock?

The financial health rating of BUILDERS FIRSTSOURCE INC (BLDR) is 4 / 10.


What is the earnings growth outlook for BUILDERS FIRSTSOURCE INC?

The Earnings per Share (EPS) of BUILDERS FIRSTSOURCE INC (BLDR) is expected to decline by -11.26% in the next year.